Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort

International Journal of Cancer

Volumn 137, Issue 5, 2015, Pages 1196-1208

  Fortner, Renée T ^a   Ose, Jennifer ^a   Merritt, Melissa A ^b   Schock, Helena ^a   Tjønneland, Anne ^c   Hansen, Louise ^c   Overvad, Kim ^d   Dossus, Laure ^e,f   Clavel Chapelon, Françoise ^e,f   Baglietto, Laura ^g,h   Boeing, Heiner ⁱ   Trichopoulou, Antonia ^j,k,l   Benetou, Vassiliki ^l   Lagiou, Pagona ^k,l,m   Agnoli, Claudia ⁿ   Mattiello, Amalia ^o   Masala, Giovanna ^p   Tumino, Rosario ^q   Sacerdote, Carlotta ^r   Bueno De Mesquita, H B ^b,s,t,u   Onland Moret, N Charlotte ^t   Peeters, Petra H ^t   Weiderpass, Elisabete ^v,w,x,y   Torhild Gram, Inger ^v   Duell, Eric J ^z   Larrañaga, Nerea ^aa,ab   Ardanaz, Eva ^ab,ac   Sánchez, María José ^ab,ad   Chirlaque, M D ^ab,ae   Brändstedt, Jenny ^af,ag   Idahl, Annika ^ah   Lundin, Eva ^ah   Khaw, Kay Tee ^ai   Wareham, Nick ^ai   Travis, Ruth C ^aj   Rinaldi, Sabina ^ak   Romieu, Isabelle ^ak   Gunter, Marc J ^b   Riboli, Elio ^b   Kaaks, Rudolf ^a   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

^e CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^f UNIVERSITÉ PARIS SACLAY   (France)

^g CANCER EPIDEMIOLOGY CENTRE   (Australia)

^h UNIVERSITY OF MELBOURNE   (Australia)

ⁱ GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^j HELLENIC HEALTH FOUNDATION   (Greece)

^k BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^l UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^m HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

ⁿ NATIONAL CANCER INSTITUTE   (Italy)

^o UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^p CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^q CIVILE M P AREZZO HOSPITAL   (Italy)

^r UNIVERSITY OF TURIN   (Italy)

^s NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^t UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^u UNIVERSITY OF MALAYA   (Malaysia)

^v UNIVERSITY OF TROMSØ   (Norway)

^w CANCER REGISTRY OF NORWAY   (Norway)

^x KAROLINSKA INSTITUTE   (Sweden)

^y FOLKHÄLSAN RESEARCH CENTER   (Finland)

^z CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^aa BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^ab CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^ac INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^ad UNIVERSITY OF GRANADA   (Spain)

^ae Murcia Regional Health Authority   (Spain)

^af LUND UNIVERSITY   (Sweden)

^ag LUND UNIVERSITY HOSPITAL   (Sweden)

^ah UMEÅ UNIVERSITY   (Sweden)

^ai UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^aj UNIVERSITY OF OXFORD   (United Kingdom)

^ak INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

more..

Author keywords

dualistic model; histologic subtype; ovarian cancer; reproductive factors

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CANCER GRADING; CANCER REGISTRY; CLEAR CELL CARCINOMA; COLLOID CARCINOMA; CONTRACEPTIVE BEHAVIOR; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROUS CARCINOMA; TUMOR INVASION; AGED; CLINICAL TRIAL; EUROPE; MIDDLE AGED; MULTICENTER STUDY; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PATHOLOGY; RISK FACTOR; TERM BIRTH;

ADULT; AGED; CONTRACEPTIVES, ORAL, HORMONAL; EUROPE; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS; TERM BIRTH;

EID: 84931565618     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29471     Document Type: Article

References (25)

1. Schüler S, Ponnath M, Engel J, et al., Ovarian epithelial tumors and reproductive factors: a systematic review. Arch Gynecol Obstet 2013; 287: 1187-204.
2. Shih I-M, Kurman RJ,. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 2004; 164: 1511-8.
3. Kurman RJ, Shin I-M,. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer. Hum Pathol 2011; 42: 918-31.
4. Merritt MA, De Pari M, Vitonis AF, et al., Reproductive characteristics in relation to ovarian cancer risk by histologic pathways. Hum Reprod 2013; 28: 1406-17.
5. Chiaffarino F, Parazzini F, Bosetti C, et al., Risk factors for ovarian cancer histotypes. Eur J Cancer 2007; 43: 1208-13.
6. Kurian AW, Balise RR, McGuire V, et al., Histologic types of epithelial ovarian cancer: have they different risk factors?. Gynecol Oncol 2005; 96: 520-30.
7. Modugno F, Ness RB, Wheeler JE,. Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness. Ann Epidemiol 2001; 11: 568-74.
8. Tung K-H, Goodman MT, Wu AH, et al., Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study. Am J Epidemiol 2003; 158: 629-38.
9. Yang HP, Trabert B, Murphy MA, et al., Ovarian cancer risk factors by histologic subtypes in the NIH-AARP diet and health study. Int J Cancer 2011; 131: 938-48.
10. Gates MA, Rosner BA, Hecht JL, et al., Risk factors for epithelial ovarian cancer by histologic subtype. Am J Epidemiol 2010; 171: 45-53.
11. Risch HA, Marrett LD, Jain M, et al., Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. Am J Epidemiol 1996; 144: 363-72.
12. Olsen CM, Nagle CM, Whiteman DC, et al., Obesity and risk of ovarian cancer subtypes: evidence from the ovarian cancer association consortium. Endocr Relat Cancer 2013; 20: 251-62.
13. Collaborative Group on Epidemiological Studies of Ovarian Cancer, Beral V, Doll R, et al., Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 2008; 371: 303-14.
14. Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies. PLoS Med 2012; 9: e1001200.
15. Riboli E, Hunt KJ, Slimani N, et al., European prospective investigation into cancer and nutrition (EPIC): study populations and data collection. Public Health Nutr 2002; 5: 1113-24.
16. Riboli E,. Nutrition and cancer: background and rationale of the European prospective investigation into cancer and nutrition (EPIC). Ann Oncol 1992; 3: 783-91.
17. Haftenberger M, Lahmann PH, Panico S, et al., Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European prospective investigation into cancer and nutrition (EPIC). Public Health Nutr 2007; 5: 1147.
18. Lunn M, McNeil D,. Applying Cox regression to competing risks. Biometrics 1995; 51: 524-32.
19. Dossus L, Allen N, Kaaks R, et al., Reproductive risk factors and endometrial cancer: the European prospective investigation into cancer and nutrition. Int J Cancer 2010; 127: 442-51.
20. Heuch I, Albrektsen G, Kvåle G,. Modeling effects of age at and time since delivery on subsequent risk of cancer. Epidemiology 1999; 10: 739-46.
21. Poole EM, Merritt MA, Jordan SJ, et al., Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness. Cancer Epidemiol Biomarkers Prev 2013; 22: 429-37.
22. Fathalla MF,. Incessant ovulation-a factor in ovarian neoplasia?. Lancet 1971; 2: 163.
23. Adami HO, Hsieh CC, Lambe M, et al., Parity, age at first childbirth, and risk of ovarian cancer. Lancet 1994; 344: 1250-4.
24. Ose J, Fortner RT, Rinaldi S, et al., Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European prospective investigation into cancer and nutrition. Int J Cancer 2015; 136: 399-410.
25. Karageorgi S, Hankinson SE, Kraft P, et al., Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the nurses' health study cohort 1976-2004. Int J Cancer 2010; 126: 208-16.